Atlas Trials

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Clinical trial NCT07537673 · RECRUITING

Trial details

NCT number
NCT07537673
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Start date
2025-11-25
Primary completion
2026-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.